Navigation Links
Most People With Arthritis Do Little Or No Exercise At All

American Journal of Preventive Medicine in its May issue has stated that most of the people suffering from arthritis don’t exercise enough, which is highly recommended by the medical experts, or don’t exercise at all. //

“People with arthritis are not meeting physical activity recommendations made at the federal level and by experts in the arthritis field,” said co-author Jennifer Hootman, Ph.D., of the Centers for Disease Control and Prevention. “That’s not good, because we know that being more active is beneficial for arthritis.”

While exercise has been shown to decrease their pain, delay disability and improve gait and function, people with arthritis are even more likely to be inactive than adults in the general population.

“These findings are not surprising,” said Kate Lorig, a professor at the Stanford University School of Medicine, who was not involved with the study. “What’s important for people with arthritis to realize is that the most dangerous type of exercise is not to do any.”

Accordingly to a survey, just 37 percent of adults with arthritis met the least stringent physical activity guidelines established by a panel of experts in arthritis, physical activity and public health in 2001 — a percentage similar to people without arthritis.

But participation rates at the more rigorous federally recommended levels of physical activity were even lower for people with arthritis — 30 percent compared with 33 percent for people without arthritis.

Twenty percent of people with arthritis reported performing some type of activity to strengthen their muscles. Both aerobic and strengthening exercises have been shown to help people with arthritis.

People with arthritis least likely to be physically active were those who had difficulty walking up ten stairs, grasping small objects, bending or kneeling, lifting ten pounds or standing for two hours.

The authors say that fear of
'"/>




Page: 1 2

Related medicine news :

1. Bad News for Short People
2. New hope on the Horizon for People Wishing to Quit Smoking
3. Prescription Drug - Helps People Stop Smoking
4. More People Seeking Treatment for Depression
5. Pain Common in People with MS
6. People with skin cancer at higher risk for other types
7. Laser Therapy Found To Help People Quit Smoking
8. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
9. New Treatment For People Allergic To Cats
10. People who fight wars may be at high risk of cardiovascular disease
11. People suffering from Alzheimer’s: can they take decisions about their treatment
Post Your Comments:
Breaking Medicine Technology:Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Navigating in the ocean of molecules 9514 1Navigating in the ocean of molecules 9514 2Navigating in the ocean of molecules 9514 3NIH stimulus funding supports Emory biomedical scientists 9512 1NIH stimulus funding supports Emory biomedical scientists 9512 2NIH stimulus funding supports Emory biomedical scientists 9512 3NIH stimulus funding supports Emory biomedical scientists 9512 4Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 1Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 2Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 3
Other Medicine Technology:Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 2Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 3Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7